FinTrust Capital Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-287
Closed -$6K 1256
2022
Q2
$6K Hold
287
﹤0.01% 1009
2022
Q1
$6K Hold
287
﹤0.01% 1044
2021
Q4
$6K Hold
287
﹤0.01% 1005
2021
Q3
$6K Hold
287
﹤0.01% 1003
2021
Q2
$8K Sell
287
-22
-7% -$595 ﹤0.01% 975
2021
Q1
$8K Hold
309
﹤0.01% 953
2020
Q4
$6K Hold
309
﹤0.01% 931
2020
Q3
$5 Buy
309
+249
+415% +$5.31K ﹤0.01% 963
2020
Q2
$2K Sell
60
-55
-48% -$1.37K ﹤0.01% 941
2020
Q1
$3K Hold
115
﹤0.01% 958
2019
Q4
$3K Hold
115
﹤0.01% 951
2019
Q3
$2K Buy
115
+8
+7% +$219 ﹤0.01% 994
2019
Q2
$3K Buy
+107
New +$3.35K ﹤0.01% 922

Other funds holding PAHC

FinTrust Capital Advisors's PAHC Position: Q3 2022 in Review

FinTrust Capital Advisors sold out of Phibro Animal Health (PAHC) in Q3 2022, closing a stake of 287 shares — an estimated $6K sold.

FinTrust Capital Advisors first reported a position in PAHC in Q2 2019 and held it in 13 quarters. The position peaked at $8K in Q2 2021. 149 funds tracked by Wall St. Rank hold PAHC as of Q3 2022.

  • FinTrust Capital Advisors reported no remaining Phibro Animal Health position as of Q3 2022 after selling out during the quarter.
  • FinTrust Capital Advisors sold 287 Phibro Animal Health shares in Q3 2022, an estimated $6K.
  • FinTrust Capital Advisors first reported a position in Phibro Animal Health in Q2 2019 and held it in 13 quarters.
  • FinTrust Capital Advisors's Phibro Animal Health position peaked at $8K in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2022.

Based on FinTrust Capital Advisors's 13F filing for Q3 2022, filed 20 Oct 2022.